跳至主要内容
临床试验/IRCT2015040921669N1
IRCT2015040921669N1已完成3 期

Effect of intravenous N-acetylcysteine on prevention of atrial fibrillation after Coronary Artery Bypass Graft surgery(CABG)

Mazandaran University of Medical Sciences0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 75 years(—)
性别
All

入选标准

  • Patient's willingness to participate in the study and getting informed consent from them; Non-emergency CABG surgery; Using cardiopulmonary bypass pump; No history of cardiac tachyarrhythmias before surgery (including AF); Having sinus rhythm; Hemodynamic stability (50 MAP> and heart rate between 50-110); and age between 35 and 75 years.
  • Exclusion criteria: Heart failure patients with ejection fraction (EF) less than 30%; History of COPD, Hyperthyroidism; Occurrence of postoperative MI; Need to pacemaker post-operatively; Re-operation for any reason; Previous history of heart surgery; Use of anti-arrhythmic drugs (with the exception of beta-blockers); Using Inotropic drugs more than the usual dose (epinephrine infusion more than 0.1 mcg / kg / min and dopamine and dobutamine infuson more than 10 mcg / kg / min)

排除标准

  • 未提供

研究者

相似试验